APLN and breast cancer: As tumor apelin expression or its receptor APJ have been associated with poor survival in humans23–26, we hypothesized that the apelinergic system could also be implicated in the adverse relation between obesity and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in BC patients.